looking for a DOT qualified SAP?

All DOT regulated safety-sensitive employees/candidates employed in the aviation, railroad, public transit, trucking, maritime, and pipeline industries who have violated federal DOT drug and alcohol testing rules with a positive test result, a refusal to test or other violation.

If you fall under Federal Aviation (FAA), Federal Motor Carrier Safety Administration (FMCSA), Federal Railroad Administration (FRA), Federal Transit Administration (FTA), Pipeline and Hazardous Materials Safety Administration (PHMSA) or the United States Coast Guard (USCG) and you failed or refused a DOT drug and/or alcohol test you must still complete the return-to-duty process in order to return to safety-sensitive duty.

The honest answer is the time it takes to complete the SAP portion of the DOT return-to-duty process varies per case. The SAP will make a clinical assessment and recommend treatment and/or education based on your individual needs. Note: The SAP must make a recommendation for some level of care per DOT CFR 49 Part 40, Subpart O and is required to refer their recommendations outside of their office. Beware if a SAP gives you an exact timeline on when you can complete the RTD process and recommendations before you start the process.

Yes. Once you have violated the Department of Transportation (DOT) drug and alcohol testing regulations, you are considered ineligible to perform safety-sensitive duties for any employer until you have completed the return-to-duty process.

Psilocybin mushrooms, known as magic mushrooms, is a hallucinogenic matter. Although taking Psilocybin will not land you a positive DOT 5 panel drug test it is an impairing substance and dangerous to consume, especially in a safety-sensitive role at work. Mushrooms are consumed fresh, cooked, smoked and even brewed into tea due to their bitterness. Mushrooms have been mixed in tobacco and cannabis. Cannabis is tested in the DOT 5 panel drug test and it will result in a positive test.

Non-psychoactive CBD oil is used to treat anxiety, inflammation, arthritis, epilepsy and a range of other conditions in some cases. In many states, a prescription is not necessary to purchase CBD oil. The production of CBD products remains unregulated by the Food and Drug Administration (FDA) and CBD products that contain more than a 0.3% concentration of THC are classified as marijuana, a Schedule I substance, as classified by the United States Drug Enforcement Agency (DEA). The Department of Transportation (DOT) has their own notice regarding CBD use.

The Office of Drug and Alcohol Policy and Compliance (ODAPC) that prevails over DOT 49 CFR Part 40 has also provided notice on CBD products. The DOT requires testing on marijuana THCA metabolites and not CBD. Marijuana remains classified as a Schedule I drug under the Controlled Substance Act. CBD product labeling may be misleading and contain higher levels of THC, which could result in a verified positive drug test. CBD products are NOT currently certified by the FDA and have issued caution to the public: “Consumers should beware purchasing and using any [CBD] products.” The notice can be viewed here.

The requirement to downgrade commercial driver’s license (CDLs) of drivers in a “prohibited” Clearinghouse status rests on the safety-critical premise that drivers who cannot lawfully operate a commercial motor vehicle (CMV) because they engaged in prohibited use of drugs or alcohol or refused a drug or alcohol test should not hold a valid CDL or commercial learner’s permit (CLP). The Clearinghouse-II final rule (86 FR 55718) supports FMCSA’s goal of ensuring that only qualified drivers are eligible to receive and retain a CDL, thereby reducing the number and severity of CMV crashes.

The Clearinghouse-II final rule (86 FR 55718) requires that, beginning November 18, 2024, State Driver Licensing Agencies (SDLAs) must remove the commercial driving privileges from the driver’s license of an individual subject to the CMV driving prohibition. This would result in a downgrade of the license until the driver completes the return-to-duty (RTD) process.

Source: https://clearinghouse.fmcsa.dot.gov/FAQ/Topics/CDL-Downgrades

Yes, you must test negative on an observed DOT return-to-duty (RTD) drug/alcohol screen before returning to DOT safety-sensitive work. Your employer or prospective employer will request the RTD test, which supersedes a pre-employment test in this situation. You are also subject to unannounced and observed follow-up tests for a period of 1 to 5 years according to a plan determined by the SAP and provided to your employer.